Figure 7From: Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancerMR imaging of FMNP-labeled MSCs targeting gastric cancer cells. The coronal and transected images of MRI show that MSCs firstly presented in the tumor tissue at 7 days post-injection and then gradually accumulated in the tumor tissue and reached peak value at 14 days post-injection.Back to article page